Stockreport

argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update

argenx SE - American Depositary Shares  (ARGX) 
PDF - Completion of enrollment expected by year-end for ADAPT-SC and ADVANCE (IV) trials of efgartigimod; topline data for both trials expected in first half of 2022 [Read more]